(Q24609511)

English

Sarcosine as a potential prostate cancer biomarker and therapeutic target

scientific article

In more languages

default for all languages

No label defined

No description defined

edit

Statements

instance of

scholarly article

0 references

title

Sarcosine as a potential prostate cancer biomarker and therapeutic target (English)

0 references

0 references

1 reference

William Douglas Figg, Sr.

series ordinal

3

object named as

William D Figg

0 references

author name string

Caitlin E Baum

series ordinal

1

0 references

Douglas K Price

series ordinal

2

0 references

language of work or name

English

0 references

publication date

1 March 2010

0 references

published in

Cancer Biology and Therapy

0 references

volume

9

0 references

issue

5

0 references

page(s)

341-2

0 references

cites work

Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874119

retrieved

7 April 2017

Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874119

retrieved

7 April 2017

The polycomb group protein EZH2 is involved in progression of prostate cancer

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874119

retrieved

7 April 2017

New molecular biomarkers for the prognosis and management of prostate cancer--the post PSA era.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874119

retrieved

27 September 2017

Prostate-specific antigen and prostate cancer: prediction, detection and monitoring.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874119

retrieved

27 September 2017

Contrast-enhanced ultrasound imaging of prostate cancer.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874119

retrieved

27 September 2017

Prostate cancer imaging

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874119

retrieved

28 November 2018

Identifiers

DOI

10.4161/CBT.9.5.11310

0 references

PMC publication ID

2874119

0 references

PubMed publication ID

20150759

0 references

ResearchGate publication ID

41425169

0 references

(Q24609511)

Sarcosine as a potential prostate cancer biomarker and therapeutic target

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)